{Reference Type}: Journal Article
{Title}: Impact of cross-reactivity and herd immunity on SARS-CoV-2 pandemic severity.
{Author}: Owusu-Boaitey N;Böttcher L;He D;Erkhembayar R;Yang L;Kim DH;Barchuk A;Gorski DH;Howard J;
{Journal}: Infect Dis (Lond)
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 12
{Factor}: 5.838
{DOI}: 10.1080/23744235.2024.2388222
{Abstract}: Public health systems reported low mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in East Asia, in low-income countries, and for children during the first year of the SARS-CoV-2 pandemic. These reports led commentators to suggest that cross-reactive immunity from prior exposure to other pathogens reduced fatality risk. Resolution of initial infection waves also contributed to speculation that herd immunity prevented further waves prior to vaccination. Serology instead implied that immunity was too limited to achieve herd immunity and that there was little impact from cross-reactive protection. Paediatric deaths exceeded those from influenza, with higher age-specific fatality risk in lower-income nations and similar fatality risk in East Asia compared with demographically similar regions. Neither pre-outbreak exposure to related pathogens nor immunity induced by initial infection waves are necessarily a reliable response to future pathogen outbreaks. Preparedness for future pathogen outbreaks should instead focus on strategies such as voluntary behavioural changes, nonpharmaceutical interventions, and vaccination.